Phospholipase C Enzymes as Bidirectional Regulators of Macrophage Immunocompetence and Intraphagosomal Fate During Mycobacterium Tuberculosis Infection (Review)
Litsenziya: cc-by-nd
Annotatsiya
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), reclaimed its position as the leading cause of death from a single infectious agent, with 1.25 million deaths reported in 2023. The ability of Mtb to establish a replicative niche inside alveolar macrophages — the very cells responsible for its destruction — depends on the subversion of host intracellular signalling. Phospholipase C (PLC) enzymes, which hydrolyse phosphatidylinositol 4,5-bisphosphate into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3), occupy a uniquely contested position in this host—pathogen dialogue: they are simultaneously indispensable effectors of macrophage antimicrobial activation and exploitable substrates of Mtb immune evasion. Objective — to construct a comprehensive mechanistic framework delineating how host PLC isoforms and bacterially encoded Mtb phospholipases C (plcA—plcD) exert opposing regulatory influences on macrophage activation state, phagosomal maturation dynamics, and cell death modality, and to evaluate contemporary evidence supporting PLC pathways as targets for host-directed therapy. Materials and methods. A systematic review of peer-reviewed literature was conducted across PubMed/MEDLINE, Scopus, and Web of Science for the period January 2020 — December 2025, in accordance with the PRISMA 2020 statement. Eligible studies addressed PLC biology in macrophage activation, Mtb virulence, phagosome biology, host cell death, or host-directed therapy; review articles were used for contextualisation. Results and discussion. Host PLC isoforms drive pro-inflammatory macrophage activation through the DAG/protein kinase C/NF-κB and IP3/Ca2+/calmodulin cascades, supporting reactive oxygen and nitrogen species output and phagolysosome biogenesis. PLCε1 emerges as a non-redundant host-protective factor: it is the most strongly suppressed gene in TB progressors in cross-species transcriptomic analyses, and its genetic ablation increases lung bacterial burden and M2 polarisation in mice. Conversely, Mtb-encoded PLCs are upregulated within hours of phagocytosis, hydrolyse host membrane phospholipids, suppress the COX-2/PGE2 axis, and favour necrotic over apoptotic macrophage death — a modality that promotes bacterial dissemination. In parallel, mannose-capped lipoarabinomannan intercepts the PLC-derived IP3—Ca2+ transient required for calmodulin-dependent PI3K-hVPS34 activation, arresting phagosome maturation at a pre-lysosomal stage. The balance between PGE2-driven apoptosis and necrosis/pyroptosis is now recognised as a determinant of disease trajectory. Conclusions. The PLC signalling axis constitutes a molecular fault line at the macrophage—Mtb interface, simultaneously supporting host defence and being co-opted for immune subversion. Pharmacological augmentation of the host PLCε1 pathway, selective inhibition of mycobacterial PLCs, restoration of the PGE2/COX-2 axis, and rescue of phagosomal Ca2+ signalling represent mechanistically grounded avenues for host-directed TB therapy that warrant further preclinical and clinical investigation.
Hali tarjima qilinmagan